The global Urinary Tract Infection Therapeutic Market Growth Accelerated by Rising Incidences of Urinary Tract Infections

 

Urinary tract infections are among the most common bacterial infections caused by the presence and growth of harmful microorganisms in the urinary tract. Left untreated, urinary tract infections can have serious consequences and even lead to sepsis. With growing incidences of urinary tract infections across both men and women, the demand for effective urinary tract infection therapeutics has increased significantly. This has propelled pharmaceutical companies to focus on developing novel and improved anti-infective drugs to treat urinary tract infections.

The global Urinary Tract Infection Therapeutic Market is estimated to be valued at US$ 8,665.5 Mn in 2023 and is expected to exhibit a CAGR of 3.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:

The rising incidences of urinary tract infections across both male and female populations is one of the key trends driving the growth of the urinary tract infection therapeutic market. As per estimates, nearly 150 million people suffer from urinary tract infections worldwide each year, with women being affected more often than men. Increased antibiotic resistance has further fueled the incidences of urinary tract infections globally. Pharmaceutical companies are investing heavily in research and development of novel anti-infective molecules to combat growing antibiotic resistance and provide more effective treatment options for urinary tract infections. This will likely remain a key growth-driving trend over the forecast period.


Segment Analysis


The global urinary tract infection therapeutic market is dominated by the antibiotics segment, which holds over 60% share of the overall market. Antibiotics such as fluoroquinolones, trimethoprim, cefoxitin, and cephalosporins are commonly prescribed to treat urinary tract infections, as they are effective against a wide variety of bacteria. Their widespread adoption can be attributed to their efficacy and low cost.

Key Takeaways

The global urinary tract infection therapeutic market is expected to witness high growth over the forecast period of 2023 to 2030. The rising prevalence of urinary tract infections due to growing elderly population and high rates of obesity are major factors driving market growth. The global Urinary Tract Infection Therapeutic Market is estimated to be valued at US$ 8,665.5 Mn in 2023 and is expected to exhibit a CAGR of 3.0% over the forecast period 2023 to 2030.

Regional analysis: North America currently dominates the global market and is expected to continue its leading position throughout the forecast period. High awareness about hygiene and availability of advanced treatment options contribute to the region's large market share. Asia Pacific is anticipated to be the fastest growing regional market for urinary tract infection therapeutics, spurred by increasing accessibility of healthcare infrastructure and rising disposable income levels in developing countries such as India and China.

Key players: Key players operating in the urinary tract infection therapeutic market are Pfizer, Novartis AG, Cipla Inc., Bayer AG, AstraZeneca, Shionogi & Co. Ltd., and GlaxoSmithKline PLC, among others. Pfizer holds the leading market position, backed by its strong product portfolio and global distribution network. Other major players are focusing on new launches and acquisitions to strengthen their market presence.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more